Analyst Ratings For Horizon Pharma PLC (NASDAQ:HZNP)
Today, Cantor Fitzgerald reiterated its Buy rating on Horizon Pharma PLC (NASDAQ:HZNP) with a price target of $13.00.
There are 2 hold ratings, 10 buy ratings on the stock.
The current consensus rating on Horizon Pharma PLC (NASDAQ:HZNP) is Buy (Score: 2.83) with a consensus target price of $19.33 per share, a potential 58.99% upside.
Some recent analyst ratings include
- 7/31/2017-Cantor Fitzgerald Reiterated Rating of Buy.
- 7/28/2017-BMO Capital Markets Reiterated Rating of Buy.
- 7/14/2017-Jefferies Group LLC Reiterated Rating of Buy.
- 5/9/2017-Stifel Nicolaus Reiterated Rating of Buy .
Recent Insider Trading Activity For Horizon Pharma PLC (NASDAQ:HZNP)
Horizon Pharma PLC (NASDAQ:HZNP) has insider ownership of 3.20% and institutional ownership of 84.09%.
- On 5/10/2017 Michael G Grey, Director, bought 10,000 with an average share price of $9.48 per share and the total transaction amounting to $94,800.00. View SEC Filing
- On 3/1/2017 Robert Carey, EVP, sold 31,808 with an average share price of $16.03 per share and the total transaction amounting to $509,882.24. View SEC Filing
- On 8/2/2016 Jeffrey W. Sherman, EVP, sold 2,900 with an average share price of $20.00 per share and the total transaction amounting to $58,000.00. View SEC Filing
- On 6/15/2016 Virinder Nohria, Director, sold 25,000 with an average share price of $17.69 per share and the total transaction amounting to $442,250.00. View SEC Filing
- On 2/26/2016 Jeffrey W Sherman, EVP, sold 4,100 with an average share price of $20.00 per share and the total transaction amounting to $82,000.00. View SEC Filing
- On 12/10/2015 Jeffrey W Sherman, EVP, sold 4,456 with an average share price of $20.00 per share and the total transaction amounting to $89,120.00. View SEC Filing
- On 9/21/2015 Jeffrey W Sherman, EVP, sold 7,750 with an average share price of $31.78 per share and the total transaction amounting to $246,295.00. View SEC Filing
Recent Trading Activity for Horizon Pharma PLC (NASDAQ:HZNP)
Shares of Horizon Pharma PLC closed the previous trading session at 12.16 down -0.50 -3.95% with shares trading hands.